Which one of the following is NOT true in relation to angiotensin converting enzyme (ACE) inhibitor?
**Core Concept:** Angiotensin Converting Enzyme (ACE) inhibitors are a class of medications used for the treatment of hypertension, heart failure, and diabetic nephropathy. They work by inhibiting the angiotensin-converting enzyme, which leads to reduced formation of angiotensin II - a potent vasoconstrictor and aldosterone stimulator. This results in vasodilation, decreased aldosterone secretion, and subsequent reduction in blood pressure and cardiac workload.
**Why the Correct Answer is Right:** ACE inhibitors are a cornerstone in the treatment of hypertension and heart failure due to their vasodilatory and anti-inflammatory properties. By inhibiting the formation of angiotensin II, they counteract the renin-angiotensin-aldosterone system (RAAS) activation. This leads to reduced vasoconstriction, decreased aldosterone secretion, and ultimately results in improved blood pressure control, reduced cardiac workload, and improved outcomes in patients with heart failure.
**Why Each Wrong Option is Incorrect:**
A. This statement is incorrect because ACE inhibitors are a well-established treatment for hypertension, heart failure, and diabetic nephropathy. They work by inhibiting the RAAS, leading to vasodilation and reduced blood pressure.
B. This statement is inaccurate as ACE inhibitors not only reduce blood pressure but also improve cardiac workload and outcomes in patients with heart failure through their vasodilatory and anti-inflammatory effects.
C. This statement is wrong because ACE inhibitors exert their therapeutic effects by inhibiting the RAAS and reducing angiotensin II formation.
D. This statement is incorrect as ACE inhibitors are known to have beneficial effects in hypertension, heart failure, and diabetic nephropathy by inhibiting the RAAS and reducing angiotensin II formation.
**Clinical Pearl:** ACE inhibitors are a powerful tool in the management of various cardiovascular disorders. They have a broad range of actions beyond blood pressure reduction, including improved cardiac workload, anti-inflammatory effects, and renoprotection in diabetic nephropathy. These medications are a cornerstone of treatment in hypertension, heart failure, and diabetic nephropathy.